Amlodipine Besylate Tablet
Product Images NDC 82804-969

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Amlodipine Besylate (NDC 82804-969). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Proficient Rx Lp, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

82804-971-30 (10mg Label)

82804-971-30 (10mg Label)
Label for Amlodipine Besylate 10 mg tablets by Proficient Rx LP, indicating a quantity of 30 tablets. The label states each tablet contains amlodipine besylate equivalent to 10 mg amlodipine. Tablets are described as white to off-white, round with a flat face and beveled edges, debossed with '023' on one side and an 'O' logo on the other. Manufactured by Oxford Pharmaceuticals, LLC, Birmingham, Alabama.*
FDA Label Image

82804-969-30 (2.5mg Label.jpg)

82804-969-30 (2.5mg Label.jpg)
Label for Amlodipine Besylate 2.5 mg tablets, packaged by Proficient Rx LP. It indicates the package contains 30 tablets, each with amlodipine besylate equivalent to 2.5 mg amlodipine. The tablets are described as white to off-white, round, flat-faced with beveled edges, debossed with '021' on one side and an 'O' logo on the other. Manufactured by Oxford Pharmaceuticals, LLC, Birmingham, Alabama.*
FDA Label Image

82804-970-30 (5mg Label)

82804-970-30 (5mg Label)
Label for Amlodipine Besylate 5 mg tablets by Proficient Rx LP. The package contains 30 oral tablets, each containing amlodipine besylate equivalent to 5 mg of amlodipine. Tablets are described as white to off-white, round, flat-faced with beveled edges, debossed with "022" on one side and an "O" logo on the other. Manufactured by Oxford Pharmaceuticals, LLC in Birmingham, Alabama.*
FDA Label Image

Figure-1 (Figure1)

Figure-1 (Figure1)
A Kaplan-Meier event rate curve comparing Amlodipine and Placebo over 24 months. The y-axis shows event rate, and the x-axis shows time in months. The chart includes hazard ratio, confidence interval, p-value, and numbers at risk at different time points for both groups.*
FDA Label Image

Figure-2 (Figure2)

Figure-2 (Figure2)
A forest plot showing hazard ratios with 95% confidence intervals comparing Amlodipine versus placebo across various patient subgroups including overall, age categories, gender, baseline sitting systolic blood pressure, baseline vessel disease, baseline vessels with stenosis, and PCI-stent strata. The x-axis represents hazard ratios from 0.0 to 2.0, with markers indicating effect estimates and confidence intervals for each subgroup. A note indicates the mean sitting baseline systolic blood pressure is 129 mmHg.*
FDA Label Image

Structure (Structure)

Structure (Structure)
Chemical structure of amlodipine besylate showing its molecular composition including chlorine, oxygen, nitrogen, and sulfur atoms arranged in a specific configuration.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.